Literature DB >> 12625251

[Adenosine--neurotransmitter and neuromodulator in the central nervous system].

Małgorzata Romanowska1, Michał Komoszyński.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12625251

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


× No keyword cloud information.
  5 in total

1.  The effects of the adenosine A3 receptor agonist IB-MECA on sodium taurocholate-induced experimental acute pancreatitis.

Authors:  Beata Prozorow-Krol; Agnieszka Korolczuk; Grazyna Czechowska; Maria Slomka; Agnieszka Madro; Krzysztof Celinski
Journal:  Arch Pharm Res       Date:  2013-09       Impact factor: 4.946

Review 2.  Computer-aided Drug Design Applied to Parkinson Targets.

Authors:  Hamilton M Ishiki; Jose Maria Barbosa Filho; Marcelo S da Silva; Marcus T Scotti; Luciana Scotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging.

Authors:  Dan Liu; Jianpeng Huang; Shanshan Gao; Hongtao Jin; Jiuming He
Journal:  Acta Pharm Sin B       Date:  2022-03-31       Impact factor: 14.903

4.  Adenosine A(2A) receptors in Parkinson's disease treatment.

Authors:  Marek Cieślak; Michał Komoszyński; Andrzej Wojtczak
Journal:  Purinergic Signal       Date:  2008-04-26       Impact factor: 3.765

5.  Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Nikola Zmarzły; Aleksandra Skubis; Bartosz Sikora; Celina Kruszniewska-Rajs; Joanna Gola; Urszula Mazurek; Eugeniusz Kucharz
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.